CLINICAL_TRIALS
trial_result
· 2025-08-08
Clinical Trial Update: Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients [Phase 2]
Summary
A Phase 2 study evaluating aflibercept for idiopathic choroidal neovascularization in young patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Idiopathic Choroidal Neovascularization | Phase 2 | Status: COMPLETED